These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 15132880)

  • 21. Determinants for the progression from impaired glucose tolerance to non-insulin-dependent diabetes mellitus.
    Nijpels G
    Eur J Clin Invest; 1998 Sep; 28 Suppl 2():8-13. PubMed ID: 9777321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance.
    Mauvais-Jarvis F; Sobngwi E; Porcher R; Riveline JP; Kevorkian JP; Vaisse C; Charpentier G; Guillausseau PJ; Vexiau P; Gautier JF
    Diabetes; 2004 Mar; 53(3):645-53. PubMed ID: 14988248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications.
    Unger RH
    Diabetes; 1995 Aug; 44(8):863-70. PubMed ID: 7621989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Early changes in the function of pancreatic beta cells and insulin pulsatility as predictors of type 2 diabetes].
    Pørksen N
    Diabetes Metab; 1999 Dec; 25 Suppl 7():14-6. PubMed ID: 10746005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Islet-cell abnormalities in non-insulin-dependent diabetes mellitus.
    Raskin P
    Am J Med; 1985 Aug; 79(2B):2-5. PubMed ID: 3898829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Examining the effects of hyperglycemia on pancreatic endocrine function in humans: evidence for in vivo glucotoxicity.
    Solomon TP; Knudsen SH; Karstoft K; Winding K; Holst JJ; Pedersen BK
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4682-91. PubMed ID: 23043193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta-cell dysfunction and insulin resistance in type 2 diabetes: role of metabolic and genetic abnormalities.
    LeRoith D
    Am J Med; 2002 Oct; 113 Suppl 6A():3S-11S. PubMed ID: 12431757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin secretion in type 2 diabetes: clinical aspects.
    Boitard C
    Diabetes Metab; 2002 Dec; 28(6 Suppl):4S33-8. PubMed ID: 12703063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of beta-cell function impairment in first-degree relatives of type 2 diabetic subjects: modeling analysis of 24-h triple-meal tests.
    Mari A; Gastaldelli A; Natali A; Ostergard T; Schmitz O; Ferrannini E
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E541-6. PubMed ID: 15522997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of type 2 diabetes: insulin resistance and beta-cell function.
    Chiasson JL; Rabasa-Lhoret R
    Diabetes; 2004 Dec; 53 Suppl 3():S34-8. PubMed ID: 15561919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo beta-cell function at the transition to early non-insulin-dependent diabetes mellitus.
    Swinburn BA; Gianchandani R; Saad MF; Lillioja S
    Metabolism; 1995 Jun; 44(6):757-64. PubMed ID: 7783660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin resistance as the core defect in type 2 diabetes mellitus.
    Goldstein BJ
    Am J Cardiol; 2002 Sep; 90(5A):3G-10G. PubMed ID: 12231073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type 2 diabetes, insulin secretion and beta-cell mass.
    Ahrén B
    Curr Mol Med; 2005 May; 5(3):275-86. PubMed ID: 15892647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta-cell loss and glucose induced signalling defects in diabetes mellitus caused by mitochondrial tRNALeu(UUR) gene mutation.
    Oka Y; Katagiri H; Ishihara H; Asano T; Kobayashi T; Kikuchi M
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S98-102. PubMed ID: 8894492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anatomical and functional plasticity of pancreatic beta-cells and type 2 diabetes].
    Cerasi E; Ktorza A
    Med Sci (Paris); 2007 Oct; 23(10):885-94. PubMed ID: 17937902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes.
    Kahn SE
    Diabetologia; 2003 Jan; 46(1):3-19. PubMed ID: 12637977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreatic β-cell identity, glucose sensing and the control of insulin secretion.
    Rutter GA; Pullen TJ; Hodson DJ; Martinez-Sanchez A
    Biochem J; 2015 Mar; 466(2):203-18. PubMed ID: 25697093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose.
    Abdul-Ghani MA; Tripathy D; DeFronzo RA
    Diabetes Care; 2006 May; 29(5):1130-9. PubMed ID: 16644654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of islet amyloid in type 2 diabetes mellitus.
    Höppener JW; Lips CJ
    Int J Biochem Cell Biol; 2006; 38(5-6):726-36. PubMed ID: 16459127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta-cells in type 2 diabetes: a loss of function and mass.
    Maedler K; Donath MY
    Horm Res; 2004; 62 Suppl 3():67-73. PubMed ID: 15539803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.